Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Outros
|
A clinical study of samuraciclib (CT7001), a first-in-class, oral, selective inhibitor of CDK7, in patients with advanced triple negative breast cancer (TNBC)Howell, Sacha J ; Kenny, Laura M ; Lord, Simon ; Krebs, Matthew G ; Arkenau, Tobias ; Baird, Richard ; MacPherson, Iain R ; Bahl, Ash ; Clack, Glen ; Ainscow, Edward ; Barrett, Anthony GM ; Dickinson, Paul A ; Fuchter, Matthew J ; Lehnert, Manfred ; Ali, Simak ; McIntosh, Stuart ; Coombes, CharlesCANCER RESEARCH 2022Texto completo disponível |
|
2 |
Material Type: Outros
|
|
|
3 |
Material Type: Outros
|
|
|
4 |
Material Type: Outros
|
|
|
5 |
Material Type: Outros
|
|
|
6 |
Material Type: Outros
|
|
|
7 |
Material Type: Outros
|
|
|
8 |
Material Type: Outros
|
|
|
9 |
Material Type: Outros
|
|
|
10 |
Material Type: Outros
|
|